5-Year Outcomes With a Novel Coronary Sirolimus-Eluting Bioresorbable Scaffold

待确认 10 由哒哒发布于 2026/3/9 21:23:35

DOI:10.1016/j.jcin.2025.06.036
作者：Kai Xu MD , Guosheng Fu MD , Xiaozeng Wang MD , Lei Song MD , Ling Tao MD , Lang Li MD , Yuqing Hou MD , Xi Su MD , Quan Fang MD , Lianglong Chen MD ,&nbsp
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：BackgroundPrevious trials have demonstrated increased 5-year risks for adverse clinical events after coronary artery implantation of poly-l-lactic acid–based bioresorbable scaffolds (BRS) co

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

23小时前

Quartz

202603100912310213411.pdf

1天前

Book学术机器人

8153f3701b8011f1a73134735aa3bc31.pdf 已驳回

1天前

Book学术机器人

2026/3/9 21:23:35 Book学术AI机器人已找到文献并上传

2026/3/9 21:23:35 Book学术AI机器人收到请求，开始寻找文献

2026/3/9 21:23:35 已向机器人发送请求

1天前

哒哒发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice